{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:29:54Z","timestamp":1793374194196,"version":"4.5.0"},"reference-count":231,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1038\/nrneurol.2017.191","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:06:49Z","timestamp":1517530009000},"page":"151-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":286,"title":["Congenital myopathies: disorders of excitation\u2013contraction coupling and muscle contraction"],"prefix":"10.1038","volume":"14","author":[{"given":"Heinz","family":"Jungbluth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Treves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zorzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sarkozy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Ochala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sewry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Gautel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"key":"BFnrneurol2017191_CR1","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/brain\/79.4.610","volume":"79","author":"KR Magee","year":"1956","unstructured":"Magee, K. R. & Shy, G. M. A new congenital non-progressive myopathy. Brain 79, 610\u2013621 (1956).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR2","first-page":"666","volume":"46","author":"AG Engel","year":"1971","unstructured":"Engel, A. G., Gomez, M. R. & Groover, R. V. Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo Clin. Proc. 46, 666\u2013681 (1971).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrneurol2017191_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archneur.1966.00470070005001","volume":"14","author":"AJ Spiro","year":"1966","unstructured":"Spiro, A. J., Shy, G. M. & Gonatas, N. K. Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch. Neurol. 14, 1\u201314 (1966).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2017191_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/brain\/86.4.793","volume":"86","author":"GM Shy","year":"1963","unstructured":"Shy, G. M., Engel, W. K., Somers, J. E. & Wanko, T. Nemaline myopathy. a new congenital myopathy. Brain 86, 793\u2013810 (1963).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR5","doi-asserted-by":"publisher","first-page":"ra68","DOI":"10.1126\/scisignal.aad9813","volume":"9","author":"RJ Lopez","year":"2016","unstructured":"Lopez, R. J.  et al. An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities. Sci. Signal. 9, ra68 (2016).","journal-title":"Sci. Signal."},{"key":"BFnrneurol2017191_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nan.12385","volume":"43","author":"H Jungbluth","year":"2017","unstructured":"Jungbluth, H. Myopathology in times of modern imaging. Neuropathol. Appl. Neurobiol. 43, 24\u201343 (2017).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrneurol2017191_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/ene.12713","volume":"22","author":"M Snoeck","year":"2015","unstructured":"Snoeck, M.  et al. RYR1-related myopathies: a wide spectrum of phenotypes throughout life. Eur. J. Neurol. 22, 1094\u20131112 (2015).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2017191_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/WCO.0000000000000372","volume":"29","author":"H Jungbluth","year":"2016","unstructured":"Jungbluth, H. & Voermans, N. C. Congenital myopathies: not only a paediatric topic. Curr. Opin. Neurol. 29, 642\u2013650 (2016).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnrneurol2017191_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ng0993-51","volume":"5","author":"KA Quane","year":"1993","unstructured":"Quane, K. A.  et al. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat. Genet. 5, 51\u201355 (1993).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2017191_CR10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1126\/science.1862346","volume":"253","author":"J Fujii","year":"1991","unstructured":"Fujii, J.  et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 253, 448\u2013451 (1991).","journal-title":"Science"},{"key":"BFnrneurol2017191_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/JND-150092","volume":"2","author":"V Biancalana","year":"2015","unstructured":"Biancalana, V. & Laporte, J. Diagnostic use of massively parallel sequencing in neuromuscular diseases: towards an integrated diagnosis. J. Neuromuscul. Dis. 2, 193\u2013203 (2015).","journal-title":"J. Neuromuscul. Dis."},{"key":"BFnrneurol2017191_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.spen.2011.10.005","volume":"18","author":"H Jungbluth","year":"2011","unstructured":"Jungbluth, H., Sewry, C. A. & Muntoni, F. Core myopathies. Semin. Pediatr. Neurol. 18, 239\u2013249 (2011).","journal-title":"Semin. Pediatr. Neurol."},{"key":"BFnrneurol2017191_CR13","volume-title":"Muscle Biopsy: a Practical Approach","author":"V Dubowitz","year":"2013","unstructured":"Dubowitz, V., Sewry, C. A. & Oldfors, A. Muscle Biopsy: a Practical Approach 4th edn (Saunders, 2013)."},{"key":"BFnrneurol2017191_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ana.22510","volume":"70","author":"K Amburgey","year":"2011","unstructured":"Amburgey, K.  et al. Prevalence of congenital myopathies in a representative pediatric United States population. Ann. Neurol. 70, 662\u2013665 (2011).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.nmd.2017.01.009","volume":"27","author":"P Hackman","year":"2017","unstructured":"Hackman, P., Udd, B., Bonnemann, C. G., Ferreiro, A. & Titinopathy Database Consortium. 219th ENMC International Workshop Titinopathies International database of titin mutations and phenotypes, Heemskerk, The Netherlands, 29 April-1 May 2016. Neuromuscul. Disord. 27, 396\u2013407 (2017).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1212\/WNL.59.2.284","volume":"59","author":"H Jungbluth","year":"2002","unstructured":"Jungbluth, H.  et al. Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology 59, 284\u2013287 (2002).","journal-title":"Neurology"},{"key":"BFnrneurol2017191_CR17","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/01.wnl.0000188870.37076.f2","volume":"65","author":"H Jungbluth","year":"2005","unstructured":"Jungbluth, H.  et al. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology 65, 1930\u20131935 (2005).","journal-title":"Neurology"},{"key":"BFnrneurol2017191_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/humu.22056","volume":"33","author":"A Klein","year":"2012","unstructured":"Klein, A.  et al. Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies. Hum. Mutat. 33, 981\u2013988 (2012).","journal-title":"Hum. Mutat."},{"key":"BFnrneurol2017191_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1086\/342719","volume":"71","author":"A Ferreiro","year":"2002","unstructured":"Ferreiro, A.  et al. Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am. J. Hum. Genet. 71, 739\u2013749 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR20","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.nmd.2012.06.007","volume":"22","author":"T Cullup","year":"2012","unstructured":"Cullup, T.  et al. Mutations in MYH7 cause multi-minicore disease (MmD) with variable cardiac involvement. Neuromuscul. Disord. 22, 1096\u20131104 (2012).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.nmd.2016.06.005","volume":"26","author":"K Takayama","year":"2016","unstructured":"Takayama, K.  et al. Japanese multiple epidermal growth factor 10 (MEGF10) myopathy with novel mutations: a phenotype\u2013genotype correlation. Neuromuscul. Disord. 26, 604\u2013609 (2016).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR22","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/mus.25054","volume":"53","author":"T Liewluck","year":"2016","unstructured":"Liewluck, T.  et al. Adult-onset respiratory insufficiency, scoliosis, and distal joint hyperlaxity in patients with multiminicore disease due to novel Megf10 mutations. Muscle Nerve 53, 984\u2013988 (2016).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol2017191_CR23","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/ng.995","volume":"43","author":"CV Logan","year":"2011","unstructured":"Logan, C. V.  et al. Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD). Nat. Genet. 43, 1189\u20131192 (2011).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2017191_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10048-012-0315-z","volume":"13","author":"SE Boyden","year":"2012","unstructured":"Boyden, S. E.  et al. Mutations in the satellite cell gene MEGF10 cause a recessive congenital myopathy with minicores. Neurogenetics 13, 115\u2013124 (2012).","journal-title":"Neurogenetics"},{"key":"BFnrneurol2017191_CR25","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/hmg\/ddt494","volume":"23","author":"C Chauveau","year":"2014","unstructured":"Chauveau, C.  et al. Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. Hum. Mol. Genet. 23, 980\u2013991 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR26","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1093\/brain\/awg244","volume":"126","author":"NB Romero","year":"2003","unstructured":"Romero, N. B.  et al. Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia. Brain 126, 2341\u20132349 (2003).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR27","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1212\/WNL.0b013e31821f467c","volume":"76","author":"M Scoto","year":"2011","unstructured":"Scoto, M.  et al. SEPN1-related myopathies: clinical course in a large cohort of patients. Neurology 76, 2073\u20132078 (2011).","journal-title":"Neurology"},{"key":"BFnrneurol2017191_CR28","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/archneurol.2011.188","volume":"68","author":"A Klein","year":"2011","unstructured":"Klein, A.  et al. Muscle MRI in congenital myopathies due to ryanodine receptor type 1 gene mutations. Arch. Neurol. 68, 1171\u20131179 (2011).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2017191_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.nmd.2004.08.006","volume":"14","author":"H Jungbluth","year":"2004","unstructured":"Jungbluth, H.  et al. Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul. Disord. 14, 785\u2013790 (2004).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1172-2-21","volume":"2","author":"H Rosenberg","year":"2007","unstructured":"Rosenberg, H., Davis, M., James, D., Pollock, N. & Stowell, K. Malignant hyperthermia. Orphanet J. Rare Dis. 2, 21 (2007).","journal-title":"Orphanet J. Rare Dis."},{"key":"BFnrneurol2017191_CR31","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1093\/hmg\/ddl221","volume":"15","author":"H Zhou","year":"2006","unstructured":"Zhou, H.  et al. Characterization of recessive RYR1 mutations in core myopathies. Hum. Mol. Genet. 15, 2791\u20132803 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR32","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.nmd.2015.04.007","volume":"25","author":"N Kraeva","year":"2015","unstructured":"Kraeva, N.  et al. Compound RYR1 heterozygosity resulting in a complex phenotype of malignant hyperthermia susceptibility and a core myopathy. Neuromuscul. Disord. 25, 567\u2013576 (2015).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.nmd.2011.03.006","volume":"21","author":"JJ Dowling","year":"2011","unstructured":"Dowling, J. J.  et al. King\u2013Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul. Disord. 21, 420\u2013427 (2011).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR34","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/ncomms2952","volume":"4","author":"EJ Horstick","year":"2013","unstructured":"Horstick, E. J.  et al. Stac3 is a component of the excitation\u2013contraction coupling machinery and mutated in Native American myopathy. Nat. Commun. 4, 1952 (2013).","journal-title":"Nat. Commun."},{"key":"BFnrneurol2017191_CR35","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","volume":"23","author":"N Dlamini","year":"2013","unstructured":"Dlamini, N.  et al. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis. Neuromuscul. Disord. 23, 540\u2013548 (2013).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/brain\/89.3.569","volume":"89","author":"J Bethlem","year":"1966","unstructured":"Bethlem, J., van Gool, J., Hulsmann, W. C. & Meijer, A. E. Familial non-progressive myopathy with muscle cramps after exercise. A new disease associated with cores in the muscle fibres. Brain 89, 569\u2013588 (1966).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR37","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00415-012-6817-7","volume":"260","author":"S L\u00f8seth","year":"2013","unstructured":"L\u00f8seth, S.  et al. A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene. J. Neurol. 260, 1504\u20131510 (2013).","journal-title":"J. Neurol."},{"key":"BFnrneurol2017191_CR38","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.nmd.2009.02.005","volume":"19","author":"H Jungbluth","year":"2009","unstructured":"Jungbluth, H.  et al. Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul. Disord. 19, 344\u2013347 (2009).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1750-1172-3-26","volume":"3","author":"H Jungbluth","year":"2008","unstructured":"Jungbluth, H., Wallgren-Pettersson, C. & Laporte, J. Centronuclear (myotubular) myopathy. Orphanet J. Rare Dis. 3, 26 (2008).","journal-title":"Orphanet J. Rare Dis."},{"key":"BFnrneurol2017191_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ng0696-175","volume":"13","author":"J Laporte","year":"1996","unstructured":"Laporte, J.  et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13, 175\u2013182 (1996).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2017191_CR41","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ng1657","volume":"37","author":"M Bitoun","year":"2005","unstructured":"Bitoun, M.  et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat. Genet. 37, 1207\u20131209 (2005).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2017191_CR42","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1093\/brain\/awu272","volume":"137","author":"J B\u00f6hm","year":"2014","unstructured":"B\u00f6hm, J.  et al. Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations. Brain 137, 3160\u20133170 (2014).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR43","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ana.22119","volume":"68","author":"JM Wilmshurst","year":"2010","unstructured":"Wilmshurst, J. M.  et al. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann. Neurol. 68, 717\u2013726 (2010).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR44","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ng2086","volume":"39","author":"AS Nicot","year":"2007","unstructured":"Nicot, A. S.  et al. Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat. Genet. 39, 1134\u20131139 (2007).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2017191_CR45","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1212\/WNL.0b013e3182a6ca62","volume":"81","author":"O Ceyhan-Birsoy","year":"2013","unstructured":"Ceyhan-Birsoy, O.  et al. Recessive truncating titin gene. TTN, mutations presenting as centronuclear myopathy. Neurology 81, 1205\u20131214 (2013).","journal-title":"Neurology"},{"key":"BFnrneurol2017191_CR46","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ajhg.2014.07.004","volume":"95","author":"PB Agrawal","year":"2014","unstructured":"Agrawal, P. B.  et al. SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy. Am. J. Hum. Genet. 95, 218\u2013226 (2014).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ajhg.2012.06.012","volume":"91","author":"K Majczenko","year":"2012","unstructured":"Majczenko, K.  et al. Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores. Am. J. Hum. Genet. 91, 365\u2013371 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR48","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1093\/hmg\/ddl250","volume":"15","author":"V Tosch","year":"2006","unstructured":"Tosch, V.  et al. A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Hum. Mol. Genet. 15, 3098\u20133106 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00401-008-0472-1","volume":"117","author":"JA Bevilacqua","year":"2009","unstructured":"Bevilacqua, J. A.  et al. \u201cNecklace\u201d fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy. Acta Neuropathol. 117, 283\u2013291 (2009).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2017191_CR50","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.nmd.2010.07.273","volume":"20","author":"T Liewluck","year":"2010","unstructured":"Liewluck, T., Lovell, T. L., Bite, A. V. & Engel, A. G. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation. Neuromuscul. Disord. 20, 801\u2013804 (2010).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00401-010-0754-2","volume":"121","author":"A Toussaint","year":"2011","unstructured":"Toussaint, A.  et al. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies. Acta Neuropathol. 121, 253\u2013266 (2011).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2017191_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.nmd.2010.01.014","volume":"20","author":"NB Romero","year":"2010","unstructured":"Romero, N. B. Centronuclear myopathies: a widening concept. Neuromuscul. Disord. 20, 223\u2013228 (2010).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR53","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0022-3476(99)70417-8","volume":"134","author":"GE Herman","year":"1999","unstructured":"Herman, G. E., Finegold, M., Zhao, W., de Gouyon, B. & Metzenberg, A. Medical complications in long-term survivors with X-linked myotubular myopathy. J. Pediatr. 134, 206\u2013214 (1999).","journal-title":"J. Pediatr."},{"key":"BFnrneurol2017191_CR54","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/humu.22067","volume":"33","author":"J Bohm","year":"2012","unstructured":"Bohm, J.  et al. Mutation spectrum in the large GTPase dynamin 2, and genotype\u2013phenotype correlation in autosomal dominant centronuclear myopathy. Hum. Mutat. 33, 949\u2013959 (2012).","journal-title":"Hum. Mutat."},{"key":"BFnrneurol2017191_CR55","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/ana.21235","volume":"62","author":"M Bitoun","year":"2007","unstructured":"Bitoun, M.  et al. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset. Ann. Neurol. 62, 666\u2013670 (2007).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nmd.2009.10.005","volume":"20","author":"H Jungbluth","year":"2010","unstructured":"Jungbluth, H.  et al. Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation. Neuromuscul. Disord. 20, 49\u201352 (2010).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR57","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ng1514","volume":"37","author":"S Zuchner","year":"2005","unstructured":"Zuchner, S.  et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot\u2013Marie\u2013Tooth disease. Nat. Genet. 37, 289\u2013294 (2005).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2017191_CR58","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.nmd.2013.08.006","volume":"23","author":"H Jungbluth","year":"2013","unstructured":"Jungbluth, H., Wallgren-Pettersson, C. & Laporte, J. F. 198th ENMC International Workshop: 7th Workshop on Centronuclear (Myotubular) Myopathies, 31st May\u20132nd June 2013, Naarden, The Netherlands. Neuromuscul. Disord. 23, 1033\u20131043 (2013).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR59","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1073\/pnas.96.5.2305","volume":"96","author":"K Pelin","year":"1999","unstructured":"Pelin, K.  et al. Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc. Natl Acad. Sci. USA 96, 2305\u20132310 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017191_CR60","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0960-8966(02)00066-4","volume":"12","author":"K Pelin","year":"2002","unstructured":"Pelin, K.  et al. Nebulin mutations in autosomal recessive nemaline myopathy: an update. Neuromuscul. Disord. 12, 680\u2013686 (2002).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR61","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/13837","volume":"23","author":"KJ Nowak","year":"1999","unstructured":"Nowak, K. J.  et al. Mutations in the skeletal muscle \u03b1-actin gene in patients with actin myopathy and nemaline myopathy. Nat. Genet. 23, 208\u2013212 (1999).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2017191_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ng0195-75","volume":"9","author":"NG Laing","year":"1995","unstructured":"Laing, N. G.  et al. A mutation in the \u03b1 tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat. Genet. 9, 75\u201379 (1995).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2017191_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0960-8966(01)00252-8","volume":"12","author":"K Donner","year":"2002","unstructured":"Donner, K.  et al. Mutations in the \u03b2-tropomyosin (TPM2) gene \u2014 a rare cause of nemaline myopathy. Neuromuscul. Disord. 12, 151\u2013158 (2002).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR64","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.ajhg.2010.10.020","volume":"87","author":"N Sambuughin","year":"2010","unstructured":"Sambuughin, N.  et al. Dominant mutations in KBTBD13, a member of the BTB\/Kelch family, cause nemaline myopathy with cores. Am. J. Hum. Genet. 87, 842\u2013847 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR65","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/humu.21059","volume":"30","author":"NG Laing","year":"2009","unstructured":"Laing, N. G.  et al. Mutations and polymorphisms of the skeletal muscle \u03b1-actin gene (ACTA1). Hum. Mutat. 30, 1267\u20131277 (2009).","journal-title":"Hum. Mutat."},{"key":"BFnrneurol2017191_CR66","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ejhg.2008.60","volume":"16","author":"VL Lehtokari","year":"2008","unstructured":"Lehtokari, V. L.  et al. Identification of a founder mutation in TPM3 in nemaline myopathy patients of Turkish origin. Eur. J. Hum. Genet. 16, 1055\u20131061 (2008).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR67","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.nmd.2008.11.009","volume":"19","author":"N Monnier","year":"2009","unstructured":"Monnier, N.  et al. Absence of \u03b2-tropomyosin is a new cause of Escobar syndrome associated with nemaline myopathy. Neuromuscul. Disord. 19, 118\u2013123 (2009).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR68","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1086\/303089","volume":"67","author":"JJ Johnston","year":"2000","unstructured":"Johnston, J. J.  et al. A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am. J. Hum. Genet. 67, 814\u2013821 (2000).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR69","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1086\/510402","volume":"80","author":"PB Agrawal","year":"2007","unstructured":"Agrawal, P. B.  et al. Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2. Am. J. Hum. Genet. 80, 162\u2013167 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajhg.2013.05.004","volume":"93","author":"G Ravenscroft","year":"2013","unstructured":"Ravenscroft, G.  et al. Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy. Am. J. Hum. Genet. 93, 6\u201318 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR71","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.ajhg.2013.10.020","volume":"93","author":"VA Gupta","year":"2013","unstructured":"Gupta, V. A.  et al. Identification of KLHL41 mutations implicates BTB-Kelch-mediated ubiquitination as an alternate pathway to myofibrillar disruption in nemaline myopathy. Am. J. Hum. Genet. 93, 1108\u20131117 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR72","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1172\/JCI75199","volume":"124","author":"M Yuen","year":"2014","unstructured":"Yuen, M.  et al. Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy. J. Clin. Invest. 124, 4693\u20134708 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017191_CR73","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ana.24900","volume":"81","author":"X Lornage","year":"2017","unstructured":"Lornage, X.  et al. Recessive MYPN mutations cause cap myopathy with occasional nemaline rods. Ann. Neurol. 81, 467\u2013473 (2017).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR74","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ajhg.2016.11.017","volume":"100","author":"S Miyatake","year":"2017","unstructured":"Miyatake, S.  et al. Biallelic mutations in MYPN, encoding myopalladin, are associated with childhood-onset, slowly progressive nemaline myopathy. Am. J. Hum. Genet. 100, 169\u2013178 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR75","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3233\/JND-150085","volume":"2","author":"E Malfatti","year":"2015","unstructured":"Malfatti, E.  et al. A premature stop codon in MYO18B is associated with severe nemaline myopathy with cardiomyopathy. J. Neuromuscul. Dis. 2, 219\u2013227 (2015).","journal-title":"J. Neuromuscul. Dis."},{"key":"BFnrneurol2017191_CR76","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/ana.21200","volume":"62","author":"A Domazetovska","year":"2007","unstructured":"Domazetovska, A.  et al. Intranuclear rod myopathy: molecular pathogenesis and mechanisms of weakness. Ann. Neurol. 62, 597\u2013608 (2007).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR77","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/ana.1080","volume":"50","author":"MM Ryan","year":"2001","unstructured":"Ryan, M. M.  et al. Nemaline myopathy: a clinical study of 143 cases. Ann. Neurol. 50, 312\u2013320 (2001).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR78","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.nmd.2008.09.005","volume":"19","author":"JJ Feng","year":"2009","unstructured":"Feng, J. J. & Marston, S. Genotype\u2013phenotype correlations in ACTA1 mutations that cause congenital myopathies. Neuromuscul. Disord. 19, 6\u201316 (2009).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR79","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/mus.24765","volume":"53","author":"N Witting","year":"2016","unstructured":"Witting, N., Werlauff, U., Duno, M. & Vissing, J. Prevalence and phenotypes of congenital myopathy due to \u03b1-actin 1 gene mutations. Muscle Nerve 53, 388\u2013393 (2016).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol2017191_CR80","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0960-8966(00)00167-X","volume":"11","author":"H Jungbluth","year":"2001","unstructured":"Jungbluth, H.  et al. Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle \u03b1-actin (ACTA1) gene. Neuromuscul. Disord. 11, 35\u201340 (2001).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR81","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.bbrc.2012.04.074","volume":"421","author":"N Sambuughin","year":"2012","unstructured":"Sambuughin, N.  et al. KBTBD13 interacts with Cullin 3 to form a functional ubiquitin ligase. Biochem. Biophys. Res. Commun. 421, 743\u2013749 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneurol2017191_CR82","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/brain\/aws344","volume":"136","author":"AE Davidson","year":"2013","unstructured":"Davidson, A. E.  et al. Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies. Brain 136, 508\u2013521 (2013).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR83","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.nmd.2004.08.005","volume":"14","author":"H Jungbluth","year":"2004","unstructured":"Jungbluth, H.  et al. Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul. Disord. 14, 779\u2013784 (2004).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR84","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/01.wnl.0000269792.63927.86","volume":"70","author":"I Sato","year":"2008","unstructured":"Sato, I.  et al. Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology 70, 114\u2013122 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol2017191_CR85","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.1093\/hmg\/ddt380","volume":"22","author":"E Muhammad","year":"2013","unstructured":"Muhammad, E.  et al. Congenital myopathy is caused by mutation of HACD1. Hum. Mol. Genet. 22, 5229\u20135236 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR86","doi-asserted-by":"publisher","first-page":"e46408","DOI":"10.1371\/journal.pone.0046408","volume":"7","author":"M Maurer","year":"2012","unstructured":"Maurer, M.  et al. Centronuclear myopathy in Labrador retrievers: a recent founder mutation in the PTPLA gene has rapidly disseminated worldwide. PLoS ONE 7, e46408 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2017191_CR87","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ajpath.2016.10.002","volume":"187","author":"GL Walmsley","year":"2017","unstructured":"Walmsley, G. L.  et al. Progressive structural defects in canine centronuclear myopathy indicate a role for HACD1 in maintaining skeletal muscle membrane systems. Am. J. Pathol. 187, 441\u2013456 (2017).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol2017191_CR88","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ana.21308","volume":"63","author":"NF Clarke","year":"2008","unstructured":"Clarke, N. F.  et al. Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann. Neurol. 63, 329\u2013337 (2008).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR89","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.nmd.2010.07.274","volume":"20","author":"P Munot","year":"2010","unstructured":"Munot, P.  et al. Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia. Neuromuscul. Disord. 20, 796\u2013800 (2010).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR90","doi-asserted-by":"publisher","first-page":"E1544","DOI":"10.1002\/humu.21278","volume":"31","author":"NF Clarke","year":"2010","unstructured":"Clarke, N. F.  et al. Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion. Hum. Mutat. 31, E1544\u2013E1550 (2010).","journal-title":"Hum. Mutat."},{"key":"BFnrneurol2017191_CR91","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.20260","volume":"56","author":"NG Laing","year":"2004","unstructured":"Laing, N. G.  et al. Actin mutations are one cause of congenital fibre type disproportion. Ann. Neurol. 56, 689\u2013694 (2004).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR92","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.20761","volume":"59","author":"NF Clarke","year":"2006","unstructured":"Clarke, N. F.  et al. SEPN1: associated with congenital fiber-type disproportion and insulin resistance. Ann. Neurol. 59, 546\u2013552 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR93","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/humu.22553","volume":"35","author":"PJ Lamont","year":"2014","unstructured":"Lamont, P. J.  et al. Novel mutations widen the phenotypic spectrum of slow skeletal\/\u03b2-cardiac myosin (MYH7) distal myopathy. Hum. Mutat. 35, 868\u2013879 (2014).","journal-title":"Hum. Mutat."},{"key":"BFnrneurol2017191_CR94","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF00690806","volume":"58","author":"JM Vallat","year":"1982","unstructured":"Vallat, J. M.  et al. Coexistence of minicores, cores, and rods in the same muscle biopsy. A new example of mixed congenital myopathy. Acta Neuropathol. 58, 229\u2013232 (1982).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2017191_CR95","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-016-1656-8","volume":"133","author":"V Schartner","year":"2017","unstructured":"Schartner, V.  et al. Dihydropyridine receptor (DHPR. CACNA1S) congenital myopathy. Acta Neuropathol. 133, 517\u2013533 (2017).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2017191_CR96","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","volume":"97","author":"N Monnier","year":"2002","unstructured":"Monnier, N.  et al. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology 97, 1067\u20131074 (2002).","journal-title":"Anesthesiology"},{"key":"BFnrneurol2017191_CR97","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/hmg\/3.8.1415","volume":"3","author":"K Jurkat-Rott","year":"1994","unstructured":"Jurkat-Rott, K.  et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum. Mol. Genet. 3, 1415\u20131419 (1994).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR98","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.ajhg.2016.09.005","volume":"99","author":"GL O'Grady","year":"2016","unstructured":"O'Grady, G. L.  et al. Variants in the oxidoreductase PYROXD1 cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. Am. J. Hum. Genet. 99, 1086\u20131105 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR99","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00401-012-1024-2","volume":"125","author":"H Tajsharghi","year":"2013","unstructured":"Tajsharghi, H. & Oldfors, A. Myosinopathies: pathology and mechanisms. Acta Neuropathol. 125, 3\u201318 (2013).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2017191_CR100","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/brain\/awq083","volume":"133","author":"H Tajsharghi","year":"2010","unstructured":"Tajsharghi, H.  et al. Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations. Brain 133, 1451\u20131459 (2010).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR101","doi-asserted-by":"publisher","first-page":"14614","DOI":"10.1073\/pnas.250289597","volume":"97","author":"T Martinsson","year":"2000","unstructured":"Martinsson, T.  et al. Autosomal dominant myopathy: missense mutation (Glu-706 \u2192 Lys) in the myosin heavy chain IIa gene. Proc. Natl Acad. Sci. USA 97, 14614\u201314619 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017191_CR102","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00415-016-8154-8","volume":"263","author":"T Willis","year":"2016","unstructured":"Willis, T.  et al. A novel MYH2 mutation in family members presenting with congenital myopathy, ophthalmoplegia and facial weakness. J. Neurol. 263, 1427\u20131433 (2016).","journal-title":"J. Neurol."},{"key":"BFnrneurol2017191_CR103","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.nmd.2017.06.015","volume":"27","author":"R Tsabari","year":"2017","unstructured":"Tsabari, R., Daum, H., Kerem, E., Fellig, Y. & Dor, T. Congenital myopathy due to myosin heavy chain 2 mutation presenting as chronic aspiration pneumonia in infancy. Neuromuscul. Disord. 27, 947\u2013950 (2017).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR104","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajhg.2012.11.014","volume":"92","author":"MJ McMillin","year":"2013","unstructured":"McMillin, M. J.  et al. Mutations in ECEL1 cause distal arthrogryposis type 5D. Am. J. Hum. Genet. 92, 150\u2013156 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR105","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/hmg\/dds514","volume":"22","author":"K Dieterich","year":"2013","unstructured":"Dieterich, K.  et al. The neuronal endopeptidase ECEL1 is associated with a distinct form of recessive distal arthrogryposis. Hum. Mol. Genet. 22, 1483\u20131492 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR106","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/cge.12224","volume":"85","author":"S Shaaban","year":"2014","unstructured":"Shaaban, S.  et al. Expanding the phenotypic spectrum of ECEL1-related congenital contracture syndromes. Clin. Genet. 85, 562\u2013567 (2014).","journal-title":"Clin. Genet."},{"key":"BFnrneurol2017191_CR107","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13023-015-0364-0","volume":"10","author":"EJ Todd","year":"2015","unstructured":"Todd, E. J.  et al. Next generation sequencing in a large cohort of patients presenting with neuromuscular disease before or at birth. Orphanet J. Rare Dis. 10, 148 (2015).","journal-title":"Orphanet J. Rare Dis."},{"key":"BFnrneurol2017191_CR108","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1172\/JCI84457","volume":"126","author":"Y Bayram","year":"2016","unstructured":"Bayram, Y.  et al. Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin. J. Clin. Invest. 126, 762\u2013778 (2016).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017191_CR109","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1073\/pnas.1221400110","volume":"110","author":"B Coste","year":"2013","unstructured":"Coste, B.  et al. Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of distal arthrogryposis. Proc. Natl Acad. Sci. USA 110, 4667\u20134672 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017191_CR110","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/brain\/awv352","volume":"139","author":"IT Zaharieva","year":"2016","unstructured":"Zaharieva, I. T.  et al. Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy. Brain 139, 674\u2013691 (2016).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR111","doi-asserted-by":"publisher","first-page":"e1447","DOI":"10.1542\/peds.2013-3727","volume":"134","author":"RR Singh","year":"2014","unstructured":"Singh, R. R.  et al. Mutations in SCN4A: a rare but treatable cause of recurrent life-threatening laryngospasm. Pediatrics 134, e1447\u2013e1450 (2014).","journal-title":"Pediatrics"},{"key":"BFnrneurol2017191_CR112","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1212\/WNL.0b013e3182900380","volume":"80","author":"DX Bharucha-Goebel","year":"2013","unstructured":"Bharucha-Goebel, D. X.  et al. Severe congenital RYR1-associated myopathy: the expanding clinicopathologic and genetic spectrum. Neurology 80, 1584\u20131589 (2013).","journal-title":"Neurology"},{"key":"BFnrneurol2017191_CR113","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.nmd.2006.09.013","volume":"17","author":"J Schessl","year":"2007","unstructured":"Schessl, J.  et al. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement. Neuromuscul. Disord. 17, 28\u201332 (2007).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR114","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.nmd.2009.03.003","volume":"19","author":"NF Clarke","year":"2009","unstructured":"Clarke, N. F.  et al. Cap disease due to mutation of the beta-tropomyosin gene (TPM2). Neuromuscul. Disord. 19, 348\u2013351 (2009).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR115","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.nmd.2007.02.015","volume":"17","author":"VL Lehtokari","year":"2007","unstructured":"Lehtokari, V. L.  et al. Cap disease caused by heterozygous deletion of the \u03b2-tropomyosin gene TPM2. Neuromuscul. Disord. 17, 433\u2013442 (2007).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR116","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.nmd.2015.02.003","volume":"25","author":"CA Sewry","year":"2015","unstructured":"Sewry, C. A., Holton, J. L., Dick, D. J., Muntoni, F. & Hanna, M. G. Zebra body myopathy is caused by a mutation in the skeletal muscle actin gene (ACTA1). Neuromuscul. Disord. 25, 388\u2013391 (2015).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR117","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/nyas.12938","volume":"1356","author":"RS Lacruz","year":"2015","unstructured":"Lacruz, R. S. & Feske, S. Diseases caused by mutations in ORAI1 and STIM1. Ann. NY Acad. Sci. 1356, 45\u201379 (2015).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrneurol2017191_CR118","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1007\/BF03008347","volume":"39","author":"CP Gordon","year":"1992","unstructured":"Gordon, C. P. & Litz, S. Multicore myopathy in a patient with anhidrotic ectodermal dysplasia. Can. J. Anaesth. 39, 966\u2013968 (1992).","journal-title":"Can. J. Anaesth."},{"key":"BFnrneurol2017191_CR119","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1212\/WNL.0000000000003745","volume":"88","author":"AG Engel","year":"2017","unstructured":"Engel, A. G., Redhage, K. R., Tester, D. J., Ackerman, M. J. & Selcen, D. Congenital myopathy associated with the triadin knockout syndrome. Neurology 88, 1153\u20131156 (2017).","journal-title":"Neurology"},{"key":"BFnrneurol2017191_CR120","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.115.015397","volume":"131","author":"HM Altmann","year":"2015","unstructured":"Altmann, H. M.  et al. Homozygous\/compound heterozygous triadin mutations associated with autosomal-recessive long-QT syndrome and pediatric sudden cardiac arrest: elucidation of the triadin knockout syndrome. Circulation 131, 2051\u20132060 (2015).","journal-title":"Circulation"},{"key":"BFnrneurol2017191_CR121","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1093\/hmg\/ddv311","volume":"24","author":"M Olive","year":"2015","unstructured":"Olive, M.  et al. New cardiac and skeletal protein aggregate myopathy associated with combined MuRF1 and MuRF3 mutations. Hum. Mol. Genet. 24, 6264 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR122","doi-asserted-by":"publisher","first-page":"23389","DOI":"10.1074\/jbc.272.37.23389","volume":"272","author":"L Zhang","year":"1997","unstructured":"Zhang, L., Kelley, J., Schmeisser, G., Kobayashi, Y. M. & Jones, L. R. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J. Biol. Chem. 272, 23389\u201323397 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2017191_CR123","doi-asserted-by":"publisher","first-page":"18026","DOI":"10.1074\/jbc.M311553200","volume":"279","author":"H Park","year":"2004","unstructured":"Park, H.  et al. Comparing skeletal and cardiac calsequestrin structures and their calcium binding: a proposed mechanism for coupled calcium binding and protein polymerization. J. Biol. Chem. 279, 18026\u201318033 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2017191_CR124","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1083\/jcb.103.3.741","volume":"103","author":"B Costello","year":"1986","unstructured":"Costello, B.  et al. Characterization of the junctional face membrane from terminal cisternae of sarcoplasmic reticulum. J. Cell Biol. 103, 741\u2013753 (1986).","journal-title":"J. Cell Biol."},{"key":"BFnrneurol2017191_CR125","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1113\/jphysiol.2009.171876","volume":"587","author":"S Treves","year":"2009","unstructured":"Treves, S.  et al. Minor sarcoplasmic reticulum membrane components that modulate excitation\u2013contraction coupling in striated muscles. J. Physiol. 587, 3071\u20133079 (2009).","journal-title":"J. Physiol."},{"key":"BFnrneurol2017191_CR126","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1113\/jphysiol.2009.175083","volume":"587","author":"E Rios","year":"2009","unstructured":"Rios, E. & Gyorke, S. Calsequestrin, triadin and more: the molecules that modulate calcium release in cardiac and skeletal muscle. J. Physiol. 587, 3069\u20133070 (2009).","journal-title":"J. Physiol."},{"key":"BFnrneurol2017191_CR127","doi-asserted-by":"publisher","first-page":"9027","DOI":"10.1074\/jbc.270.16.9027","volume":"270","author":"W Guo","year":"1995","unstructured":"Guo, W. & Campbell, K. P. Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum. J. Biol. Chem. 270, 9027\u20139030 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2017191_CR128","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00424-016-1869-7","volume":"468","author":"E Wium","year":"2016","unstructured":"Wium, E., Dulhunty, A. F. & Beard, N. A. Three residues in the luminal domain of triadin impact on Trisk 95 activation of skeletal muscle ryanodine receptors. Pflugers Arch. 468, 1985\u20131994 (2016).","journal-title":"Pflugers Arch."},{"key":"BFnrneurol2017191_CR129","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1021\/bi981306+","volume":"38","author":"AH Caswell","year":"1999","unstructured":"Caswell, A. H., Motoike, H. K., Fan, H. & Brandt, N. R. Location of ryanodine receptor binding site on skeletal muscle triadin. Biochemistry 38, 90\u201397 (1999).","journal-title":"Biochemistry"},{"key":"BFnrneurol2017191_CR130","doi-asserted-by":"publisher","first-page":"12278","DOI":"10.1074\/jbc.274.18.12278","volume":"274","author":"S Groh","year":"1999","unstructured":"Groh, S.  et al. Functional interaction of the cytoplasmic domain of triadin with the skeletal ryanodine receptor. J. Biol. Chem. 274, 12278\u201312283 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2017191_CR131","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1085\/jgp.200709790","volume":"130","author":"SA Goonasekera","year":"2007","unstructured":"Goonasekera, S. A.  et al. Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling. J. Gen. Physiol. 130, 365\u2013378 (2007).","journal-title":"J. Gen. Physiol."},{"key":"BFnrneurol2017191_CR132","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1152\/physrev.2000.80.2.853","volume":"80","author":"AM Gordon","year":"2000","unstructured":"Gordon, A. M., Homsher, E. & Regnier, M. Regulation of contraction in striated muscle. Physiol. Rev. 80, 853\u2013924 (2000).","journal-title":"Physiol. Rev."},{"key":"BFnrneurol2017191_CR133","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1021\/bi015703n","volume":"41","author":"M Abu-Abed","year":"2002","unstructured":"Abu-Abed, M., Mal, T. K., Kainosho, M., MacLennan, D. H. & Ikura, M. Characterization of the ATP-binding domain of the sarco(endo)plasmic reticulum Ca2+-ATPase: probing nucleotide binding by multidimensional NMR. Biochemistry 41, 1156\u20131164 (2002).","journal-title":"Biochemistry"},{"key":"BFnrneurol2017191_CR134","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1749-6632.2003.tb07231.x","volume":"986","author":"DH MacLennan","year":"2003","unstructured":"MacLennan, D. H., Asahi, M. & Tupling, A. R. The regulation of SERCA-type pumps by phospholamban and sarcolipin. Ann. NY Acad. Sci. 986, 472\u2013480 (2003).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrneurol2017191_CR135","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrm1151","volume":"4","author":"DH MacLennan","year":"2003","unstructured":"MacLennan, D. H. & Kranias, E. G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell. Biol. 4, 566\u2013577 (2003).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"BFnrneurol2017191_CR136","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1073\/pnas.0330962100","volume":"100","author":"M Asahi","year":"2003","unstructured":"Asahi, M.  et al. Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban. Proc. Natl Acad. Sci. USA 100, 5040\u20135045 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017191_CR137","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1469-7793.2001.0185b.x","volume":"533","author":"N Kurebayashi","year":"2001","unstructured":"Kurebayashi, N. & Ogawa, Y. Depletion of Ca2+ in the sarcoplasmic reticulum stimulates Ca2+ entry into mouse skeletal muscle fibres. J. Physiol. 533, 185\u2013199 (2001).","journal-title":"J. Physiol."},{"key":"BFnrneurol2017191_CR138","doi-asserted-by":"publisher","first-page":"15793","DOI":"10.1073\/pnas.0403485101","volume":"101","author":"G Cherednichenko","year":"2004","unstructured":"Cherednichenko, G.  et al. Conformational activation of Ca2+ entry by depolarization of skeletal myotubes. Proc. Natl Acad. Sci. USA 101, 15793\u201315798 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017191_CR139","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1113\/jphysiol.2007.135046","volume":"583","author":"BS Launikonis","year":"2007","unstructured":"Launikonis, B. S. & Rios, E. Store-operated Ca2+ entry during intracellular Ca2+ release in mammalian skeletal muscle. J. Physiol. 583, 81\u201397 (2007).","journal-title":"J. Physiol."},{"key":"BFnrneurol2017191_CR140","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/ncb1731","volume":"10","author":"J Stiber","year":"2008","unstructured":"Stiber, J.  et al. STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle. Nat. Cell Biol. 10, 688\u2013697 (2008).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneurol2017191_CR141","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/ncb1435","volume":"8","author":"C Peinelt","year":"2006","unstructured":"Peinelt, C.  et al. Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat. Cell Biol. 8, 771\u2013773 (2006).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneurol2017191_CR142","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","volume":"8","author":"S Treves","year":"2008","unstructured":"Treves, S., Jungbluth, H., Muntoni, F. & Zorzato, F. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. Curr. Opin. Pharmacol. 8, 319\u2013326 (2008).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrneurol2017191_CR143","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.molmed.2012.09.006","volume":"18","author":"JH Hwang","year":"2012","unstructured":"Hwang, J. H., Zorzato, F., Clarke, N. F. & Treves, S. Mapping domains and mutations on the skeletal muscle ryanodine receptor channel. Trends Mol. Med. 18, 644\u2013657 (2012).","journal-title":"Trends Mol. Med."},{"key":"BFnrneurol2017191_CR144","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.bbamcr.2010.11.009","volume":"1813","author":"DH Maclennan","year":"2011","unstructured":"Maclennan, D. H. & Zvaritch, E. Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim. Biophys. Acta 1813, 948\u2013964 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneurol2017191_CR145","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1242\/dev.004531","volume":"134","author":"H Hirata","year":"2007","unstructured":"Hirata, H.  et al. Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease. Development 134, 2771\u20132781 (2007).","journal-title":"Development"},{"key":"BFnrneurol2017191_CR146","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/humu.22326","volume":"34","author":"H Zhou","year":"2013","unstructured":"Zhou, H.  et al. RyR1 deficiency in congenital myopathies disrupts excitation\u2013contraction coupling. Hum. Mutat. 34, 986\u2013996 (2013).","journal-title":"Hum. Mutat."},{"key":"BFnrneurol2017191_CR147","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1086\/508500","volume":"79","author":"H Zhou","year":"2006","unstructured":"Zhou, H.  et al. Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies. Am. J. Hum. Genet. 79, 859\u2013868 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR148","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1042\/BJ20051282","volume":"395","author":"S Ducreux","year":"2006","unstructured":"Ducreux, S.  et al. Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes. Biochem. J. 395, 259\u2013266 (2006).","journal-title":"Biochem. J."},{"key":"BFnrneurol2017191_CR149","doi-asserted-by":"publisher","first-page":"11881","DOI":"10.1073\/pnas.1310571110","volume":"110","author":"BR Nelson","year":"2013","unstructured":"Nelson, B. R.  et al. Skeletal muscle-specific T-tubule protein STAC3 mediates voltage-induced Ca2+ release and contractility. Proc. Natl Acad. Sci. USA 110, 11881\u201311886 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017191_CR150","doi-asserted-by":"publisher","first-page":"10986","DOI":"10.1073\/pnas.1612441113","volume":"113","author":"A Polster","year":"2016","unstructured":"Polster, A., Nelson, B. R., Olson, E. N. & Beam, K. G. Stac3 has a direct role in skeletal muscle-type excitation\u2013contraction coupling that is disrupted by a myopathy-causing mutation. Proc. Natl Acad. Sci. USA 113, 10986\u201310991 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017191_CR151","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ajhg.2012.12.007","volume":"92","author":"J Bohm","year":"2013","unstructured":"Bohm, J.  et al. Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy. Am. J. Hum. Genet. 92, 271\u2013278 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2017191_CR152","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1242\/jcs.090464","volume":"125","author":"M Volkers","year":"2012","unstructured":"Volkers, M.  et al. Orai1 deficiency leads to heart failure and skeletal myopathy in zebrafish. J. Cell Sci. 125, 287\u2013294 (2012).","journal-title":"J. Cell Sci."},{"key":"BFnrneurol2017191_CR153","doi-asserted-by":"publisher","first-page":"12485","DOI":"10.1073\/pnas.0806015105","volume":"105","author":"MJ Jurynec","year":"2008","unstructured":"Jurynec, M. J.  et al. Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle. Proc. Natl Acad. Sci. USA 105, 12485\u201312490 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017191_CR154","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.21644","volume":"65","author":"S Arbogast","year":"2009","unstructured":"Arbogast, S.  et al. Oxidative stress in SEPN1-related myopathy: from pathophysiology to treatment. Ann. Neurol. 65, 677\u2013686 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR155","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fnagi.2014.00339","volume":"6","author":"H Jungbluth","year":"2014","unstructured":"Jungbluth, H. & Gautel, M. Pathogenic mechanisms in centronuclear myopathies. Front. Aging Neurosci. 6, 339 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"BFnrneurol2017191_CR156","doi-asserted-by":"publisher","first-page":"e1002595","DOI":"10.1371\/journal.pgen.1002595","volume":"8","author":"BS Cowling","year":"2012","unstructured":"Cowling, B. S., Toussaint, A., Muller, J. & Laporte, J. Defective membrane remodeling in neuromuscular diseases: insights from animal models. PLoS Genet. 8, e1002595 (2012).","journal-title":"PLoS Genet."},{"key":"BFnrneurol2017191_CR157","first-page":"320","volume":"26","author":"C Bachmann","year":"2017","unstructured":"Bachmann, C.  et al. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations. Hum. Mol. Genet. 26, 320\u2013332 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR158","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.spen.2011.10.004","volume":"18","author":"C Wallgren-Pettersson","year":"2011","unstructured":"Wallgren-Pettersson, C., Sewry, C. A., Nowak, K. J. & Laing, N. G. Nemaline myopathies. Sem. Pediatr. Neurol. 18, 230\u2013238 (2011).","journal-title":"Sem. Pediatr. Neurol."},{"key":"BFnrneurol2017191_CR159","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/brain\/awr004","volume":"134","author":"G Ravenscroft","year":"2011","unstructured":"Ravenscroft, G.  et al. Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies. Brain 134, 1101\u20131115 (2011).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR160","doi-asserted-by":"publisher","first-page":"e28699","DOI":"10.1371\/journal.pone.0028699","volume":"6","author":"G Ravenscroft","year":"2011","unstructured":"Ravenscroft, G.  et al. Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression. PLoS ONE 6, e28699 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2017191_CR161","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1212\/WNL.0b013e31824e8ebe","volume":"78","author":"RK Jain","year":"2012","unstructured":"Jain, R. K.  et al. Nemaline myopathy with stiffness and hypertonia associated with an ACTA1 mutation. Neurology 78, 1100\u20131103 (2012).","journal-title":"Neurology"},{"key":"BFnrneurol2017191_CR162","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/ana.24535","volume":"78","author":"S Donkervoort","year":"2015","unstructured":"Donkervoort, S.  et al. TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotype. Ann. Neurol. 78, 982\u2013994 (2015).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR163","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1096\/fj.10-176727","volume":"25","author":"J Ochala","year":"2011","unstructured":"Ochala, J.  et al. Disrupted myosin cross-bridge cycling kinetics triggers muscle weakness in nebulin-related myopathy. FASEB J. 25, 1903\u20131913 (2011).","journal-title":"FASEB J."},{"key":"BFnrneurol2017191_CR164","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2044-5040-4-15","volume":"4","author":"M Marttila","year":"2014","unstructured":"Marttila, M.  et al. Nebulin interactions with actin and tropomyosin are altered by disease-causing mutations. Skelet. Muscle 4, 15 (2014).","journal-title":"Skelet. Muscle"},{"key":"BFnrneurol2017191_CR165","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/ana.24654","volume":"9","author":"JM de Winter","year":"2016","unstructured":"de Winter, J. M.  et al. Mutation-specific effects on thin filament length in thin filament myopathy. Ann. Neurol. 9, 959\u2013969 (2016).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR166","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1365-2443.2008.01226.x","volume":"13","author":"R Ajima","year":"2008","unstructured":"Ajima, R.  et al. Deficiency of Myo18B in mice results in embryonic lethality with cardiac myofibrillar aberrations. Genes Cells 13, 987\u2013999 (2008).","journal-title":"Genes Cells"},{"key":"BFnrneurol2017191_CR167","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1534\/genetics.116.192864","volume":"205","author":"R Gurung","year":"2017","unstructured":"Gurung, R.  et al. A zebrafish model for a human myopathy associated with mutation of the unconventional myosin MYO18B. Genetics 205, 725\u2013735 (2017).","journal-title":"Genetics"},{"key":"BFnrneurol2017191_CR168","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2044-5040-4-11","volume":"4","author":"VA Gupta","year":"2014","unstructured":"Gupta, V. A. & Beggs, A. H. Kelch proteins: emerging roles in skeletal muscle development and diseases. Skelet. Muscle 4, 11 (2014).","journal-title":"Skelet. Muscle"},{"key":"BFnrneurol2017191_CR169","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1172\/JCI74994","volume":"124","author":"A Garg","year":"2014","unstructured":"Garg, A.  et al. KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy. J. Clin. Invest. 124, 3529\u20133539 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017191_CR170","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/hmg\/ddq515","volume":"20","author":"P Castets","year":"2011","unstructured":"Castets, P.  et al. Satellite cell loss and impaired muscle regeneration in selenoprotein N deficiency. Hum. Mol. Genet. 20, 694\u2013704 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR171","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-213X-9-46","volume":"9","author":"P Castets","year":"2009","unstructured":"Castets, P.  et al. Selenoprotein N is dynamically expressed during mouse development and detected early in muscle precursors. BMC Dev. Biol. 9, 46 (2009).","journal-title":"BMC Dev. Biol."},{"key":"BFnrneurol2017191_CR172","doi-asserted-by":"publisher","first-page":"14697","DOI":"10.1073\/pnas.1003677107","volume":"107","author":"AH Beggs","year":"2010","unstructured":"Beggs, A. H.  et al. MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers. Proc. Natl Acad. Sci. USA 107, 14697\u201314702 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017191_CR173","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1093\/hmg\/ddq153","volume":"19","author":"JJ Dowling","year":"2010","unstructured":"Dowling, J. J., Low, S. E., Busta, A. S. & Feldman, E. L. Zebrafish MTMR14 is required for excitation\u2013contraction coupling, developmental motor function and the regulation of autophagy. Hum. Mol. Genet. 19, 2668\u20132681 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR174","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1128\/MCB.01075-12","volume":"33","author":"KM Fetalvero","year":"2013","unstructured":"Fetalvero, K. M.  et al. Defective autophagy and mTORC1 signaling in myotubularin null mice. Mol. Cell. Biol. 33, 98\u2013110 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrneurol2017191_CR175","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1096\/fj.12-220947","volume":"27","author":"L Al-Qusairi","year":"2013","unstructured":"Al-Qusairi, L.  et al. Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin\u2013proteasome pathways. FASEB J. 27, 3384\u20133394 (2013).","journal-title":"FASEB J."},{"key":"BFnrneurol2017191_CR176","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1600-0854.2012.01348.x","volume":"13","author":"AC Durieux","year":"2012","unstructured":"Durieux, A. C.  et al. A centronuclear myopathy\u2013dynamin 2 mutation impairs autophagy in mice. Traffic 13, 869\u2013879 (2012).","journal-title":"Traffic"},{"key":"BFnrneurol2017191_CR177","doi-asserted-by":"publisher","first-page":"30304","DOI":"10.1074\/jbc.M110.108720","volume":"285","author":"J Sarparanta","year":"2010","unstructured":"Sarparanta, J.  et al. Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to tibial and limb-girdle muscular dystrophies. J. Biol. Chem. 285, 30304\u201330315 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2017191_CR178","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ajmg.a.33296","volume":"152A","author":"V McClelland","year":"2010","unstructured":"McClelland, V.  et al. Vici syndrome associated with sensorineural hearing loss and evidence of neuromuscular involvement on muscle biopsy. Am. J. Med. Genet. A 152A, 741\u2013747 (2010).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrneurol2017191_CR179","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/brain\/awv393","volume":"139","author":"S Byrne","year":"2016","unstructured":"Byrne, S.  et al. EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy. Brain 139, 765\u2013781 (2016).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR180","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1093\/hmg\/ddv195","volume":"24","author":"O Rokach","year":"2015","unstructured":"Rokach, O.  et al. Epigenetic changes as a common trigger of muscle weakness in congenital myopathies. Hum. Mol. Genet. 24, 4636\u20134647 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR181","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nmd.2013.11.003","volume":"24","author":"KN North","year":"2014","unstructured":"North, K. N.  et al. Approach to the diagnosis of congenital myopathies. Neuromuscul. Disord. 24, 97\u2013116 (2014).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR182","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1212\/NXI.0000000000000057","volume":"2","author":"Y Hacohen","year":"2015","unstructured":"Hacohen, Y.  et al. Fetal acetylcholine receptor inactivation syndrome: a myopathy due to maternal antibodies. Neurol. Neuroimmunol. Neuroinflamm. 2, e57 (2015).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"BFnrneurol2017191_CR183","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jneuroim.2008.06.026","volume":"201-202","author":"M. Kinali","year":"2008","unstructured":"Kinali, M.  et al. Congenital myasthenic syndromes in childhood: diagnostic and management challenges. J. Neuroimmunol. 201\u2013202, 6\u201312 (2008).","journal-title":"Journal of Neuroimmunology"},{"key":"BFnrneurol2017191_CR184","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.nmd.2013.12.011","volume":"24","author":"CG Bonnemann","year":"2014","unstructured":"Bonnemann, C. G.  et al. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul. Disord. 24, 289\u2013311 (2014).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR185","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.nmd.2010.12.007","volume":"21","author":"D Selcen","year":"2011","unstructured":"Selcen, D. Myofibrillar myopathies. Neuromuscul. Disord. 21, 161\u2013171 (2011).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR186","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.spen.2006.06.004","volume":"13","author":"I Nishino","year":"2006","unstructured":"Nishino, I. Autophagic vacuolar myopathy. Semin. Pediatr. Neurol. 13, 90\u201395 (2006).","journal-title":"Semin. Pediatr. Neurol."},{"key":"BFnrneurol2017191_CR187","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/0883073812436605","volume":"27","author":"CH Wang","year":"2012","unstructured":"Wang, C. H.  et al. Consensus statement on standard of care for congenital myopathies. J. Child Neurol. 27, 363\u2013382 (2012).","journal-title":"J. Child Neurol."},{"key":"BFnrneurol2017191_CR188","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.semcdb.2016.08.004","volume":"64","author":"H Jungbluth","year":"2017","unstructured":"Jungbluth, H., Ochala, J., Treves, S. & Gautel, M. Current and future therapeutic approaches to the congenital myopathies. Semin. Cell Dev. Biol. 64, 191\u2013200 (2017).","journal-title":"Semin. Cell Dev. Biol."},{"key":"BFnrneurol2017191_CR189","doi-asserted-by":"publisher","first-page":"220ra10","DOI":"10.1126\/scitranslmed.3007523","volume":"6","author":"MK Childers","year":"2014","unstructured":"Childers, M. K.  et al. Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy. Sci. Transl Med. 6, 220ra10 (2014).","journal-title":"Sci. Transl Med."},{"key":"BFnrneurol2017191_CR190","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1089\/hum.2013.052","volume":"24","author":"J Rendu","year":"2013","unstructured":"Rendu, J.  et al. Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathy. Hum. Gene Ther. 24, 702\u2013713 (2013).","journal-title":"Hum. Gene Ther."},{"key":"BFnrneurol2017191_CR191","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/hmg\/ddg121","volume":"12","author":"N Monnier","year":"2003","unstructured":"Monnier, N.  et al. A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia. Hum. Mol. Genet. 12, 1171\u20131178 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR192","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1172\/JCI7866","volume":"104","author":"ER Barton-Davis","year":"1999","unstructured":"Barton-Davis, E. R., Cordier, L., Shoturma, D. I., Leland, S. E. & Sweeney, H. L. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J. Clin. Invest. 104, 375\u2013381 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017191_CR193","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tig.2012.05.001","volume":"28","author":"DG MacArthur","year":"2012","unstructured":"MacArthur, D. G. & Lek, M. The uncertain road towards genomic medicine. Trends Genet. 28, 303\u2013305 (2012).","journal-title":"Trends Genet."},{"key":"BFnrneurol2017191_CR194","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1172\/JCI71206","volume":"124","author":"BS Cowling","year":"2014","unstructured":"Cowling, B. S.  et al. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy. J. Clin. Invest. 124, 1350\u20131363 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017191_CR195","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1172\/JCI86841","volume":"126","author":"N Sabha","year":"2016","unstructured":"Sabha, N.  et al. PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models. J. Clin. Invest. 126, 3613\u20133625 (2016).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017191_CR196","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1093\/hmg\/ddt252","volume":"22","author":"G Ravenscroft","year":"2013","unstructured":"Ravenscroft, G.  et al. Cardiac \u03b1-actin over-expression therapy in dominant ACTA1 disease. Hum. Mol. Genet. 22, 3987\u20133997 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR197","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ana.21035","volume":"61","author":"KJ Nowak","year":"2007","unstructured":"Nowak, K. J.  et al. Nemaline myopathy caused by absence of \u03b1-skeletal muscle actin. Ann. Neurol. 61, 175\u2013184 (2007).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2017191_CR198","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/hmg\/ddt003","volume":"22","author":"MW Lawlor","year":"2013","unstructured":"Lawlor, M. W.  et al. Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. Hum. Mol. Genet. 22, 1525\u20131538 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017191_CR199","doi-asserted-by":"publisher","first-page":"26965","DOI":"10.1074\/jbc.272.43.26965","volume":"272","author":"BR Fruen","year":"1997","unstructured":"Fruen, B. R., Mickelson, J. R. & Louis, C. F. Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors. J. Biol. Chem. 272, 26965\u201326971 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2017191_CR200","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/ALN.0000000000000732","volume":"123","author":"MA Timmins","year":"2015","unstructured":"Timmins, M. A.  et al. Malignant hyperthermia testing in probands without adverse anesthetic reaction. Anesthesiology 123, 548\u2013556 (2015).","journal-title":"Anesthesiology"},{"key":"BFnrneurol2017191_CR201","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1213\/00000539-199802000-00055","volume":"86","author":"A Michalek-Sauberer","year":"1998","unstructured":"Michalek-Sauberer, A. & Gilly, H. Prophylactic use of dantrolene in a patient with central core disease. Anesth. Analg. 86, 915\u2013916 (1998).","journal-title":"Anesth. Analg."},{"key":"BFnrneurol2017191_CR202","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.nmd.2016.06.001","volume":"26","author":"H Jungbluth","year":"2016","unstructured":"Jungbluth, H., Dowling, J. J., Ferreiro, A. & Muntoni, F. 217th ENMC International Workshop: RYR1-related myopathies, Naarden, The Netherlands, 29\u201331 January 2016. Neuromuscul. Disord. 26, 624\u2013633 (2016).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR203","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1016\/j.ddmec.2010.09.009","volume":"7","author":"DC Andersson","year":"2010","unstructured":"Andersson, D. C. & Marks, A. R. Fixing ryanodine receptor Ca leak \u2014 a novel therapeutic strategy for contractile failure in heart and skeletal muscle. Drug Discov. Today Dis. Mech. 7, e151\u2013e157 (2010).","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"BFnrneurol2017191_CR204","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1172\/JCI62834","volume":"123","author":"AR Marks","year":"2013","unstructured":"Marks, A. R. Calcium cycling proteins and heart failure: mechanisms and therapeutics. J. Clin. Invest. 123, 46\u201352 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017191_CR205","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2337\/diabetes.54.4.928","volume":"54","author":"R Pold","year":"2005","unstructured":"Pold, R.  et al. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54, 928\u2013934 (2005).","journal-title":"Diabetes"},{"key":"BFnrneurol2017191_CR206","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nm.2598","volume":"18","author":"JT Lanner","year":"2012","unstructured":"Lanner, J. T.  et al. AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation. Nat. Med. 18, 244\u2013251 (2012).","journal-title":"Nat. Med."},{"key":"BFnrneurol2017191_CR207","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/jmedgenet-2012-101470","volume":"50","author":"JM de Winter","year":"2013","unstructured":"de Winter, J. M.  et al. Troponin activator augments muscle force in nemaline myopathy patients with nebulin mutations. J. Med. Genet. 50, 383\u2013392 (2013).","journal-title":"J. Med. Genet."},{"key":"BFnrneurol2017191_CR208","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13395-015-0037-7","volume":"5","author":"JM de Winter","year":"2015","unstructured":"de Winter, J. M.  et al. Effect of levosimendan on the contractility of muscle fibers from nemaline myopathy patients with mutations in the nebulin gene. Skelet. Muscle 5, 12 (2015).","journal-title":"Skelet. Muscle"},{"key":"BFnrneurol2017191_CR209","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/156652312800840577","volume":"12","author":"H Amthor","year":"2012","unstructured":"Amthor, H. & Hoogaars, W. M. Interference with myostatin\/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy. Curr. Gene Ther. 12, 245\u2013259 (2012).","journal-title":"Curr. Gene Ther."},{"key":"BFnrneurol2017191_CR210","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cell.2008.02.042","volume":"133","author":"WJ Durham","year":"2008","unstructured":"Durham, W. J.  et al. RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell 133, 53\u201365 (2008).","journal-title":"Cell"},{"key":"BFnrneurol2017191_CR211","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/brain\/aws036","volume":"135","author":"JJ Dowling","year":"2012","unstructured":"Dowling, J. J.  et al. Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy. Brain 135, 1115\u20131127 (2012).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR212","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00415-015-8015-x","volume":"263","author":"D Natera-de Benito","year":"2016","unstructured":"Natera-de Benito, D.  et al. KLHL40-related nemaline myopathy with a sustained, positive response to treatment with acetylcholinesterase inhibitors. J. Neurol. 263, 517\u2013523 (2016).","journal-title":"J. Neurol."},{"key":"BFnrneurol2017191_CR213","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nmd.2011.02.012","volume":"21","author":"SA Robb","year":"2011","unstructured":"Robb, S. A.  et al. Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. Neuromuscul. Disord. 21, 379\u2013386 (2011).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR214","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00109-013-0994-4","volume":"91","author":"EM Gibbs","year":"2013","unstructured":"Gibbs, E. M.  et al. Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy. J. Mol. Med. 91, 727\u2013737 (2013).","journal-title":"J. Mol. Med."},{"key":"BFnrneurol2017191_CR215","first-page":"852","volume":"5","author":"JJ Dowling","year":"2012","unstructured":"Dowling, J. J.  et al. Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models. Dis. Model. Mech. 5, 852\u2013859 (2012).","journal-title":"Dis. Model. Mech."},{"key":"BFnrneurol2017191_CR216","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1055\/s-2004-821173","volume":"35","author":"S Messina","year":"2004","unstructured":"Messina, S.  et al. Pilot trial of salbutamol in central core and multi-minicore diseases. Neuropediatrics 35, 262\u2013266 (2004).","journal-title":"Neuropediatrics"},{"key":"BFnrneurol2017191_CR217","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.1007\/s10545-010-9085-7","volume":"33","author":"LT Schreuder","year":"2010","unstructured":"Schreuder, L. T.  et al. Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction. J. Inherit. Metab. Dis. 33, S205\u2013209 (2010).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFnrneurol2017191_CR218","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.nmd.2011.12.003","volume":"22","author":"H Jungbluth","year":"2012","unstructured":"Jungbluth, H., Dowling, J. J., Ferreiro, A. & Muntoni, F. 182nd ENMC International Workshop: RYR1-related myopathies, 15\u201317th April 2011, Naarden, The Netherlands. Neuromuscul. Disord. 22, 453\u2013462 (2012).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol2017191_CR219","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1093\/brain\/awr274","volume":"134","author":"MA Nguyen","year":"2011","unstructured":"Nguyen, M. A.  et al. Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy. Brain 134, 3516\u20133529 (2011).","journal-title":"Brain"},{"key":"BFnrneurol2017191_CR220","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1177\/0883073807309794","volume":"23","author":"MM Ryan","year":"2008","unstructured":"Ryan, M. M.  et al. Dietary L-tyrosine supplementation in nemaline myopathy. J. Child Neurol. 23, 609\u2013613 (2008).","journal-title":"J. Child Neurol."},{"key":"BFnrneurol2017191_CR221","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1172\/JCI71919","volume":"124","author":"L Winter","year":"2014","unstructured":"Winter, L.  et al. Chemical chaperone ameliorates pathological protein aggregation in plectin-deficient muscle. J. Clin. Invest. 124, 1144\u20131157 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017191_CR222","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2174\/1381612821666150105160059","volume":"21","author":"M Kusaczuk","year":"2015","unstructured":"Kusaczuk, M., Bartoszewicz, M. & Cechowska-Pasko, M. Phenylbutyric acid: simple structure \u2014 multiple effects. Curr. Pharm. Des. 21, 2147\u20132166 (2015).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrneurol2017191_CR223","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.2174\/1381612811319280006","volume":"19","author":"M Cuadrado-Tejedor","year":"2013","unstructured":"Cuadrado-Tejedor, M., Ricobaraza, A. L., Torrijo, R., Franco, R. & Garcia-Osta, A. Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer's disease-like phenotype of a commonly used mouse model. Curr. Pharm. Des. 19, 5076\u20135084 (2013).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrneurol2017191_CR224","doi-asserted-by":"publisher","first-page":"14659","DOI":"10.1038\/ncomms14659","volume":"8","author":"CS Lee","year":"2017","unstructured":"Lee, C. S.  et al. A chemical chaperone improves muscle function in mice with a RyR1 mutation. Nat. Commun. 8, 14659 (2017).","journal-title":"Nat. Commun."},{"key":"BFnrneurol2017191_CR225","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/iub.1576","volume":"68","author":"H Vega","year":"2016","unstructured":"Vega, H., Agellon, L. B. & Michalak, M. The rise of proteostasis promoters. IUBMB Life 68, 943\u2013954 (2016).","journal-title":"IUBMB Life"},{"key":"BFnrneurol2017191_CR226","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/humu.23138","volume":"38","author":"P Yuste-Checa","year":"2017","unstructured":"Yuste-Checa, P.  et al. Pharmacological chaperoning: a potential treatment for PMM2-CDG. Hum. Mutat. 38, 160\u2013168 (2017).","journal-title":"Hum. Mutat."},{"key":"BFnrneurol2017191_CR227","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jmb.2007.08.055","volume":"373","author":"E Kim","year":"2007","unstructured":"Kim, E.,  et al. Characterization of human cardiac calsequestrin and its deleterious mutants. J. Mol. Biol. 373, 1047\u20131057 (2007).","journal-title":"J. Mol. Biol."},{"key":"BFnrneurol2017191_CR228","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature12775","volume":"505","author":"L Tang","year":"2014","unstructured":"Tang, L.,  et al. Structural basis for Ca2+ selectivity of a voltage-gated calcium channel. Nature 505, 56\u201361 (2014).","journal-title":"Nature"},{"key":"BFnrneurol2017191_CR229","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/S0006-3495(03)74681-5","volume":"85","author":"J Zamoon","year":"2003","unstructured":"Zamoon, J., Mascioni, A., Thomas, D. D. & Veglia, G. NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys. J. 85, 2589\u20132598 (2003).","journal-title":"Biophys. J."},{"key":"BFnrneurol2017191_CR230","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nature13916","volume":"517","author":"RG Efremov","year":"2015","unstructured":"Efremov, R. G., Leitner, A., Aebersold, R. & Raunser, S. Architecture and conformational switch mechanism of the ryanodine receptor. Nature 517, 39\u201343 (2015).","journal-title":"Nature"},{"key":"BFnrneurol2017191_CR231","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/35015017","volume":"405","author":"C Toyoshima","year":"2000","unstructured":"Toyoshima, C., Nakasako, M., Nomura, H. & Ogawa, H. Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 \u00c5 resolution. Nature 405, 647\u2013655 (2000).","journal-title":"Nature"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2017.191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2017.191","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrneurol.2017.191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2017.191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T07:12:35Z","timestamp":1650438755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2017.191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":231,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["BFnrneurol2017191"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2017.191","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,2]]},"assertion":[{"value":"2 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}